Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adrenergic Agonists: Indirect-Acting Agents

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...

Stimulants

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.

Drugs Affecting Neurotransmitter Release or Uptake

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Experimental Designs

Experimental Designs

An experimental design is a systematic process that allows researchers to evaluate the relationship between dependent and independent variables. There are three widely used types of experimental design - pre-experimental design, true experimental design, and quasi-experimental design. In pre-experimental design, the researcher compares the data before and after some interventions or treatments. The true-experimental design has more than one purposefully created group, a commonly measured...

Drugs Acting on Autonomic Ganglia: Stimulants

Drugs Acting on Autonomic Ganglia: Stimulants

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Triazole 187 is a biased KOR agonist that suppresses itch without sedation and induces anxiolytic-like behaviors in mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

Same author

Characterization of the GTPγS release function of a G protein-coupled receptor.

Nature communications·2025

Same author

GTP release-selective agonists prolong opioid analgesic efficacy.

Nature·2025

Same author

Exceptionally Potent Chiral Anandamide Analogs.

Journal of medicinal chemistry·2025

Same author

Bidirectional Modification of a <i>Galbulimima</i> Alkaloid Identifies Selective Opioid Ligands.

ACS central science·2025

Same author

Crystal structures of agonist-bound human cannabinoid receptor CB<sub>1</sub>.

Nature·2025

Search research articles

Related Experiment Video

Updated: Nov 10, 2025

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Published on: October 2, 2018

Decaf or regular? Energizing the caffeine receptor.

Edward L Stahl¹, Laura M Bohn¹

¹The Scripps Research Institute, Department of Molecular Medicine, Jupiter, FL 33458, USA.

|April 2, 2021

Summary

This summary is machine-generated.

Partial agonists have varying drug efficacy, which depends on the system and comparator drug. This study used biophysical methods to directly measure the intrinsic efficacy of G protein-coupled receptor (GPCR) partial agonists.

More Related Videos

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Published on: July 24, 2018

Related Experiment Videos

Last Updated: Nov 10, 2025

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Published on: October 2, 2018

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine

Published on: July 24, 2018

Area of Science:

Pharmacology
Biophysics
Molecular Biology

Background:

Partial agonism is a key concept in pharmacology, defining a drug's efficacy relative to a maximal response.
The intrinsic efficacy of partial agonists is system- and comparator-dependent, complicating their characterization.
G protein-coupled receptors (GPCRs) are crucial drug targets, and understanding partial agonist activity is vital for drug development.

Purpose of the Study:

To develop and apply biophysical approaches for defining the signature of GPCR partial agonists.
To provide direct, quantitative measures of the varying intrinsic efficacy of these compounds.
To elucidate the biophysical basis of partial agonism at the molecular level.

Main Methods:

Utilized advanced biophysical techniques to analyze GPCR-ligand interactions.
Developed methods for direct measurement of intrinsic efficacy.
Applied these methods to characterize specific GPCR partial agonists.

Main Results:

Successfully defined a biophysical signature for GPCR partial agonists.
Provided direct quantitative measures of intrinsic efficacy, revealing significant variations.
Demonstrated the utility of biophysical approaches in distinguishing partial agonist properties.

Conclusions:

Biophysical methods offer a robust way to characterize GPCR partial agonists.
Direct measurement of intrinsic efficacy provides crucial insights into drug action.
This work advances the understanding of partial agonism and its implications for drug design.